Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges in the treatment of hypothyroidism: malabsorption and pseudo-malabsorption of levothyroxine.

Medicina·2025
Same author

Lithium and endocrine dysfunction.

Medicina·2022
Same author

Endocrine dysfunction induced by immune checkpoint inhibitors.

Medicina·2021
Same author

Adrenal axis in critical illness.

Medicina·2021
Same author

Treatment of hypothyroidism in special situations.

Medicina·2021
Same author

Hyperprolactinemia associated with psychiatric disorders.

Medicina·2020
Same journal

[Penis synovial sarcoma: a rare case report].

Medicina·2026
Same journal

[Reflective anuria secondary to unilateral lithiasis].

Medicina·2026
Same journal

[Lemierre-like syndrome, an emerging diagnosis].

Medicina·2026
Same journal

Unusually late spinal cord metastasis of hepatocellular carcinoma after liver transplantation.

Medicina·2026
Same journal

[Abdominal Mondor's disease].

Medicina·2026
Same journal

[Anaplastic thyroid carcinoma: Importance of early diagnosis and treatment].

Medicina·2026
See all related articles

Related Experiment Video

Updated: May 25, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

[Amiodarone and thyroid dysfunction].

Leonardo F L Rizzo1, Oscar D Bruno

  • 1Estudios Metabólicos y Endocrinos, Buenos Aires. elbylen@yahoo.com.ar

Medicina
|January 20, 2012
PubMed
Summary
This summary is machine-generated.

Amiodarone, an anti-arrhythmic drug, interacts with thyroid hormone receptors, potentially causing thyroid dysfunction like hypothyroidism and thyrotoxicosis due to its slow elimination and tissue accumulation.

Related Experiment Videos

Last Updated: May 25, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

Area of Science:

  • Pharmacology
  • Endocrinology
  • Cardiology

Background:

  • Amiodarone is a potent anti-arrhythmic agent structurally similar to thyroid hormone.
  • Its lipophilic nature leads to slow elimination and tissue accumulation.
  • Amiodarone interacts with thyroid hormone nuclear receptors, influencing its actions and toxicity.

Purpose of the Study:

  • To review the updated understanding of amiodarone's effects on thyroid physiology.
  • To analyze the potential and frequent thyroidal adverse effects of amiodarone.
  • To discuss amiodarone's role in managing life-threatening arrhythmias.

Main Methods:

  • Literature review of amiodarone's pharmacological and clinical properties.
  • Analysis of amiodarone's interaction with thyroid hormone receptors.
  • Review of clinical data on amiodarone-induced thyroid dysfunction.

Main Results:

  • Amiodarone's anti-arrhythmic efficacy in various cardiac conditions is well-established.
  • Significant interactions with thyroid hormone pathways contribute to its toxicity.
  • Hypothyroidism and thyrotoxicosis are notable adverse effects of amiodarone therapy.

Conclusions:

  • Amiodarone's unique pharmacology necessitates careful consideration of its thyroidal adverse effects.
  • Understanding amiodarone's impact on thyroid function is crucial for patient management.
  • Further research is needed to optimize amiodarone use while mitigating thyroid-related complications.